{"id":"phylloquinone","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Anemia due to enzyme deficiency","Arteriosclerosis obliterans","Carcinoma of female breast","Central nervous system depression","Constipation","Dehydration","Diabetes mellitus","Hypercalcemia","Hyperparathyroidism","Hyperphosphatemia","Hypervitaminosis D","Kidney disease","Kidney stone","Malignant tumor of cervix","Neoplasm of endometrium","Neoplasm of prostate","Osteolysis","Sarcoidosis","Vitamin E deficiency"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Vitamin K1"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Alpha-synuclein"},"_scrapedAt":"2026-03-28T03:52:03.710Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Antibiotic-Induced Hypoprothrombinemia","diseaseId":"antibiotic-induced-hypoprothrombinemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anticoagulant-Induced Prothrombin Deficiency","diseaseId":"anticoagulant-induced-prothrombin-deficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Factor II deficiency","diseaseId":"factor-ii-deficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypocalcemia","diseaseId":"hypocalcemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Neonatal Hemorrhagic Disease","diseaseId":"neonatal-hemorrhagic-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Osteoporosis","diseaseId":"osteoporosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Postmenopausal osteoporosis","diseaseId":"postmenopausal-osteoporosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of Neonatal Hemorrhagic Disease","diseaseId":"prevention-of-neonatal-hemorrhagic-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vitamin K Deficiency Induced Hypoprothrombinemia","diseaseId":"vitamin-k-deficiency-induced-hypoprothrombinemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07497893","phase":"NA","title":"FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2026-12-01","conditions":"Atrial Fibrillation (AF), Upper Gastrointestinal Bleeding (UGIB), Gastrointestinal Hemorrhage (Clinically Important, Upper)","enrollment":1000},{"nctId":"NCT06521463","phase":"NA","title":"SIMPLAAFY Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2024-10-01","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":1857},{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07471139","phase":"PHASE3","title":"SWITCH: Apixaban vs Vitamin K in HM3","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-06","conditions":"LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure, Bleeding","enrollment":460},{"nctId":"NCT02592317","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2016-02-12","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":23},{"nctId":"NCT04394546","phase":"NA","title":"CHAMPION-AF Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2020-10-15","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3000},{"nctId":"NCT04618913","phase":"","title":"Anticoagulation in Patients With Venous Thromboembolism and Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-12-14","conditions":"Neoplasms, Embolism","enrollment":1},{"nctId":"NCT05038228","phase":"","title":"High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2022-08-01","conditions":"Atrial Fibrillation","enrollment":1},{"nctId":"NCT06817512","phase":"NA","title":"Ischemic Stroke Nutrition Intervention Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harbin Medical University","startDate":"2025-03-23","conditions":"Ischemic Stroke","enrollment":190},{"nctId":"NCT06655376","phase":"PHASE4","title":"Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-10-02","conditions":"Bleeding, Clot Blood","enrollment":128},{"nctId":"NCT07431762","phase":"PHASE4","title":"Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-02-01","conditions":"Valve Replacement Surgery","enrollment":1058},{"nctId":"NCT05259046","phase":"NA","title":"The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2022-06-21","conditions":"Coronary Artery Calcification, Arterial Stiffness","enrollment":450},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT07403942","phase":"NA","title":"The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial","status":"COMPLETED","sponsor":"Nanjing Ascend Biotech Technology Co., Ltd.","startDate":"2024-12-26","conditions":"Skin Aging of Face and Neck","enrollment":36},{"nctId":"NCT04226547","phase":"NA","title":"Amplatzer Amulet LAAO vs. NOAC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2020-07-07","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":2650},{"nctId":"NCT07378514","phase":"","title":"Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices","status":"NOT_YET_RECRUITING","sponsor":"LumiraDx UK Limited","startDate":"2026-04","conditions":"Blood Clots, Infection and Inflammatory Reaction, Heart Disease","enrollment":30000},{"nctId":"NCT07372170","phase":"","title":"Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients","status":"RECRUITING","sponsor":"Infanta Leonor University Hospital","startDate":"2025-12-01","conditions":"Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), Thrombophilia","enrollment":600},{"nctId":"NCT04573946","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2019-07-01","conditions":"Bone Density, Bone Health, Fractures","enrollment":25871},{"nctId":"NCT04752813","phase":"PHASE2","title":"A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)","status":"ACTIVE_NOT_RECRUITING","sponsor":"BPGbio","startDate":"2022-08-22","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":50},{"nctId":"NCT06385275","phase":"PHASE1, PHASE2","title":"The Role of Vitamin K on Knee Osteoarthritis Outcomes","status":"RECRUITING","sponsor":"Boston University","startDate":"2025-06-03","conditions":"Osteo Arthritis Knee","enrollment":55},{"nctId":"NCT06315530","phase":"PHASE2","title":"Effect of Telitacicept on Antibody Titers in Primary APS Patients","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2023-12-01","conditions":"Antiphospholipid Syndrome (APS)","enrollment":20},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07350538","phase":"NA","title":"The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Roehampton","startDate":"2025-12-10","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT07352501","phase":"NA","title":"Effectiveness of Pulsed Electromagnetic Fields and Nutraceutical Supplementation in Women With Distal Radius Fracture","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Palermo","startDate":"2025-03-10","conditions":"Fracture of Distal Radius, Bone Fractures, Wrist Injuries","enrollment":100},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT07330869","phase":"","title":"Warfarin Effects on Male Fertility After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Città di Lecce Hospital, GVM Care & Research","startDate":"2026-02","conditions":"Male Infertility, Heart Valve Disease","enrollment":90},{"nctId":"NCT07319299","phase":"NA","title":"STOP HCC-GAAD-APAC-Thailand","status":"ENROLLING_BY_INVITATION","sponsor":"Mahidol University","startDate":"2025-02-02","conditions":"Hepatecellular Carcinoma, Cirrhosis, HBV Infection","enrollment":2100},{"nctId":"NCT03636295","phase":"PHASE3","title":"Low INR to Minimize Bleeding With Mechanical Valves Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-09-05","conditions":"Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement","enrollment":2625},{"nctId":"NCT04258488","phase":"PHASE4","title":"Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement","status":"RECRUITING","sponsor":"Joon Bum Kim","startDate":"2022-02-21","conditions":"AORTIC VALVE DISEASES, Thromboembolism","enrollment":1300},{"nctId":"NCT05891119","phase":"EARLY_PHASE1","title":"Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-06-03","conditions":"Atopic Dermatitis","enrollment":21},{"nctId":"NCT06138184","phase":"NA","title":"Learning Theory Patient Education for Anticoagulants","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2026-04","conditions":"Knowledge, Attitudes, Practice","enrollment":68},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT07256769","phase":"","title":"Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis","status":"RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2025-09-29","conditions":"Osteoporosis Secondary, Breast Cancer Females","enrollment":134},{"nctId":"NCT07185295","phase":"PHASE4","title":"Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Outcomes'10","startDate":"2024-10-18","conditions":"Anticoagulated Patients","enrollment":481},{"nctId":"NCT02614573","phase":"NA","title":"International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2016-02","conditions":"Aged, Nursing Homes","enrollment":31},{"nctId":"NCT05943457","phase":"NA","title":"Vitamin K2 Supplementation in Adult Episodic Migraine","status":"RECRUITING","sponsor":"Sola Aoun Bahous, M.D. Ph.D.","startDate":"2024-03-06","conditions":"Migraine Headache, Arterial Stiffness, Vitamin K Deficiency","enrollment":160},{"nctId":"NCT06975605","phase":"PHASE1","title":"Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.","status":"COMPLETED","sponsor":"GRIN Therapeutics, Inc.","startDate":"2025-05-20","conditions":"Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders","enrollment":18},{"nctId":"NCT07206537","phase":"NA","title":"The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Pediatrics Nephrology","enrollment":60},{"nctId":"NCT06081114","phase":"NA","title":"Micronutrient Dose Response Study in Bangladesh","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-10-22","conditions":"Micronutrient Status","enrollment":643},{"nctId":"NCT04284839","phase":"PHASE3","title":"The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2021-07-18","conditions":"Bleeding Post Cardiac Surgery, Indication for Anticoagulation","enrollment":3500},{"nctId":"NCT07195760","phase":"","title":"Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2023-02-10","conditions":"Head Trauma, Head Injury, Delirium","enrollment":600},{"nctId":"NCT06665919","phase":"NA","title":"The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models","status":"COMPLETED","sponsor":"Vistamedi Ltd.","startDate":"2023-06-15","conditions":"Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis","enrollment":283},{"nctId":"NCT05971108","phase":"NA","title":"Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC","status":"RECRUITING","sponsor":"Manchester University NHS Foundation Trust","startDate":"2024-01-08","conditions":"Liver Cirrhosis, Hepatocellular Carcinoma","enrollment":600},{"nctId":"NCT05505552","phase":"NA","title":"Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tufts University","startDate":"2023-09-20","conditions":"Osteo Arthritis Knee","enrollment":37},{"nctId":"NCT03753490","phase":"NA","title":"ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University","startDate":"2018-10-25","conditions":"Atrial Fibrillation","enrollment":3933},{"nctId":"NCT07146282","phase":"","title":"Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Hassan Rostom Ibrahim","startDate":"2025-09","conditions":"Rheumatic Heart Disease","enrollment":165},{"nctId":"NCT03358706","phase":"PHASE1","title":"A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-02-02","conditions":"Crohn Disease, Ulcerative Colitis","enrollment":28},{"nctId":"NCT07125417","phase":"PHASE4","title":"Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure","status":"RECRUITING","sponsor":"OCEAN-SHD Study Group","startDate":"2025-05-29","conditions":"Nonvalvular Atrial Fibrillation, Aspirin, Non-Antithrombotic Therapy","enrollment":500},{"nctId":"NCT05018221","phase":"PHASE3","title":"Better Evidence and Translation for Calciphylaxis","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-08-26","conditions":"Calciphylaxis","enrollment":350},{"nctId":"NCT04669782","phase":"NA","title":"Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging","status":"TERMINATED","sponsor":"University of Milano Bicocca","startDate":"2020-11-24","conditions":"Bone Metabolism Disorder, Aging Disorder, Osteoporosis","enrollment":99},{"nctId":"NCT05081960","phase":"","title":"Evaluating the Vitamin K2 Status of Calcium-based Stone Formers","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2022-08-01","conditions":"Kidney Calculi, Calcium Oxalate Kidney Stones, Vitamin K 2","enrollment":60},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT07041645","phase":"NA","title":"Bioavailability of Different Vitamin K Vitamers Studied Using 13C-labelled Vitamin K Vitamers","status":"NOT_YET_RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-07-01","conditions":"Bioavailability of Vitamin K","enrollment":20},{"nctId":"NCT05942053","phase":"PHASE4","title":"Role of Vitamin K2 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT07011095","phase":"EARLY_PHASE1","title":"DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2025-09-03","conditions":"Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation)","enrollment":100},{"nctId":"NCT02318342","phase":"NA","title":"Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2014-12","conditions":"Prosthetic Valve Thrombosis","enrollment":3000},{"nctId":"NCT06429787","phase":"","title":"Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure","status":"RECRUITING","sponsor":"Octapharma","startDate":"2025-02-14","conditions":"Vitamin K-Dependent Coagulation Defect, Significant Bleeding Risk","enrollment":3574},{"nctId":"NCT04286321","phase":"NA","title":"Achieving Nutritional Adequacy Of Vitamin K With An Egg/Plant-Based Food Pairing","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2021-06-01","conditions":"Nutritional Requirements","enrollment":10},{"nctId":"NCT03129490","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":11000},{"nctId":"NCT01393821","phase":"NA","title":"Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-01-23","conditions":"Dermatologic Complications, Malignant Neoplasm, Pain","enrollment":27},{"nctId":"NCT03129555","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":5000},{"nctId":"NCT06960954","phase":"","title":"PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-01-15","conditions":"Hepato Cellular Carcinoma (HCC), Portal Vein Tumour Thrombosis","enrollment":116},{"nctId":"NCT01864122","phase":"","title":"Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death","status":"COMPLETED","sponsor":"Tufts University","startDate":"2007-01","conditions":"Cardiovascular Disease","enrollment":2448},{"nctId":"NCT06921018","phase":"NA","title":"Bioavailability of Micronutrients With a Special Focus on Vitamin K Dependent on Consumed Diet","status":"NOT_YET_RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-04-01","conditions":"Micronutrient Status","enrollment":20},{"nctId":"NCT05333666","phase":"","title":"The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-03-21","conditions":"Atrial Fibrillation","enrollment":1500},{"nctId":"NCT05500443","phase":"NA","title":"The DANish COronary DEcalcification (DANCODE) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-02-08","conditions":"Coronary Artery Disease","enrollment":400},{"nctId":"NCT06881628","phase":"PHASE4","title":"Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-12-02","conditions":"Upper Gastrointestinal Bleeding (UGIB), Variceal Bleeding, Cirrhosis","enrollment":194},{"nctId":"NCT06867952","phase":"NA","title":"A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant","status":"RECRUITING","sponsor":"S.LAB (SOLOWAYS)","startDate":"2024-05-03","conditions":"Osteoporosis, Osteopenia","enrollment":40},{"nctId":"NCT06875050","phase":"NA","title":"Antioxidant Supplements in Cystic Fibrosis Children","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-03-12","conditions":"Cystic Fibrosis (CF)","enrollment":60},{"nctId":"NCT06215430","phase":"PHASE1","title":"A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-01-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT06864052","phase":"NA","title":"The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Seoul Hospital","startDate":"2025-03-01","conditions":"Stroke, Atrial Fibrillation","enrollment":400},{"nctId":"NCT06862726","phase":"PHASE4","title":"Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation","status":"ENROLLING_BY_INVITATION","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2024-12-01","conditions":"Non Valvular Atrial Fibrillation","enrollment":120},{"nctId":"NCT06855953","phase":"NA","title":"Vitamin K and Cognition in Coronary Heart Disease (NutriCog)","status":"NOT_YET_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2025-03-17","conditions":"Coronary Heart Disease","enrollment":40},{"nctId":"NCT02798471","phase":"PHASE3","title":"Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-03-27","conditions":"Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)","enrollment":290},{"nctId":"NCT06845137","phase":"PHASE1","title":"Impact of Tactile Kinesthetic Stimulation and Soft Tissue Manipulation on Cortisol in Preterm","status":"NOT_YET_RECRUITING","sponsor":"faizan kashoo, PT","startDate":"2025-03-20","conditions":"Neonatal Disorder","enrollment":60},{"nctId":"NCT01130025","phase":"PHASE3","title":"Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-08","conditions":"Venous Thromboembolism","enrollment":900},{"nctId":"NCT06839352","phase":"PHASE4","title":"Efficacy and Safety of Intravenous Vitamin K1 in Management of Acute Variceal Bleeding","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-10-03","conditions":"Variceal Bleeding","enrollment":66},{"nctId":"NCT06402851","phase":"PHASE4","title":"Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)","status":"RECRUITING","sponsor":"Hospital Sirio-Libanes","startDate":"2024-12-18","conditions":"Atrium; Fibrillation, Chronic Kidney Diseases","enrollment":1500},{"nctId":"NCT03892824","phase":"NA","title":"Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Javelin Medical","startDate":"2019-04-15","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT06823466","phase":"","title":"Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants","status":"RECRUITING","sponsor":"University of L'Aquila","startDate":"2025-02-12","conditions":"Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF)","enrollment":200},{"nctId":"NCT05068414","phase":"","title":"Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2021-04-12","conditions":"Atrial Fibrillation, Acute Coronary Syndrome, Thrombosis","enrollment":122},{"nctId":"NCT04437654","phase":"PHASE4","title":"The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2020-07-28","conditions":"Atrial Fibrillation Patients With Intermediate Stroke Risk","enrollment":1800},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT06707909","phase":"PHASE4","title":"The Local Effect of Vitamin K2 on Bone Remodeling in Socket Preservation","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-02-15","conditions":"Socket Preservation","enrollment":20},{"nctId":"NCT05547750","phase":"NA","title":"Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population","status":"COMPLETED","sponsor":"The Third People's Hospital of Chengdu","startDate":"2022-10-01","conditions":"Nocturnal Leg Cramps","enrollment":200},{"nctId":"NCT06747312","phase":"PHASE2","title":"Effect of Belimumab on Antibody Titers in Primary APS Patients","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-04-01","conditions":"Antiphospholipid Syndrome (APS)","enrollment":20},{"nctId":"NCT04062097","phase":"","title":"Registration of Idarucizumab for Patients with IntraCranial Hemorrhage","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2019-09-19","conditions":"Intracranial Hemorrhage","enrollment":104},{"nctId":"NCT06648837","phase":"NA","title":"Microvisk Continuous Blood Donation Study","status":"NOT_YET_RECRUITING","sponsor":"Microvisk Technologies Ltd","startDate":"2025-01-13","conditions":"Pulmonary Embolism (Diagnosis), Deep Vein Thrombosis, Atrial Fibrillation (AF)","enrollment":2500},{"nctId":"NCT06692504","phase":"","title":"Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2021-01-01","conditions":"Hemorrhage, Thrombosis, Anticoagulant Therapy","enrollment":2080},{"nctId":"NCT06606275","phase":"","title":"The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on Dialysis","status":"COMPLETED","sponsor":"Abu Dhabi Health Services Company","startDate":"2024-01-01","conditions":"End-Stage Kidney Disease (ESKD), Non-valvular Atrial Fibrillation (NVAF), Venous Thromboembolism (VTE)","enrollment":67},{"nctId":"NCT02464969","phase":"PHASE4","title":"Apixaban for the Acute Treatment of Venous Thromboembolism in Children","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-11-22","conditions":"Venous Thromboembolism","enrollment":229},{"nctId":"NCT06635707","phase":"","title":"Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2024-11-01","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":600},{"nctId":"NCT05873933","phase":"NA","title":"An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes","status":"WITHDRAWN","sponsor":"Hemptress","startDate":"2024-07-01","conditions":"Acne, Eczema, Skin Aging","enrollment":""},{"nctId":"NCT05356936","phase":"NA","title":"Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2022-06-01","conditions":"Post-acute COVID-19 Syndrome","enrollment":151},{"nctId":"NCT06615596","phase":"EARLY_PHASE1","title":"Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-01","conditions":"Atrial Fibrillation (AF)","enrollment":3160},{"nctId":"NCT05285787","phase":"PHASE2","title":"A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)","status":"COMPLETED","sponsor":"Epizon Pharma, Inc.","startDate":"2019-03-01","conditions":"End-Stage Renal Disease (ESRD)","enrollment":18},{"nctId":"NCT04780061","phase":"PHASE3","title":"Dietary Supplements for COVID-19","status":"TERMINATED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2021-07-12","conditions":"Covid19","enrollment":90},{"nctId":"NCT02886962","phase":"PHASE4","title":"Oral Anticoagulation in Haemodialysis Patients","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2017-07-12","conditions":"Kidney Failure, Chronic","enrollment":50},{"nctId":"NCT04660747","phase":"","title":"Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-01-27","conditions":"Cerebral Venous Thrombosis","enrollment":1300}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1000,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"Phylloquinone","genericName":"Phylloquinone","companyName":"Guy's and St Thomas' NHS Foundation Trust","companyId":"guy-s-and-st-thomas-nhs-foundation-trust","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Phylloquinone, also known as vitamin K1, is a small molecule vitamin found in food and on the World Health Organization's List of Essential Medicines. It is used as a dietary supplement and has been studied in clinical trials for conditions such as intracranial hemorrhages and subarachnoid hemorrhage, often in conjunction with anticoagulant medications like apixaban and rivaroxaban.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1983-07-25T00:00:00.000Z","mah":"HOSPIRA","brand_name_local":"VITAMIN K1","application_number":"ANDA087954"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1983-07-25T00:00:00.000Z","mah":"HOSPIRA","brand_name_local":"VITAMIN K1","application_number":"ANDA087955"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1983-07-25T00:00:00.000Z","mah":"HOSPIRA","brand_name_local":"VITAMIN K1","application_number":"ANDA087956"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}